Pharmaceutical major Dr. Reddy's Laboratories reduces employee costs by approximately 25%, including voluntary retirement for high-paid employees.
Employees aged 50-55 in the R&D division have been offered voluntary retirement, and high-salaried employees across various departments have been asked to resign.
The downsizing aligns with Dr. Reddy's efforts to enhance operational efficiencies and could result in a potential shutdown of the therapeutics division and downsizing in the nutraceuticals arm.
A 25% reduction in workforce costs could yield annual savings of approximately Rs 1,300 crore for the company.